Costello Syndrome prognosis

Costello syndrome is a rare genetic disorder caused by mutations in the HRAS gene, and while it involves significant health complexities, proactive multidisciplinary care significantly improves long-term outcomes. While individuals with Costello syndrome face an increased risk of certain malignancies and cardiovascular issues, modern surveillance protocols allow for earlier intervention and a better quality of life than previously possible.

What determines the long-term prognosis for Costello syndrome?

The prognosis for Costello syndrome is highly variable, as the condition affects multiple body systems, including the heart, growth, and neurological development. Because Costello syndrome is a multisystem disorder, long-term health depends heavily on the severity of the specific HRAS mutation and the timing of clinical interventions. Early diagnosis allows families to establish a medical home, which is essential for managing the chronic nature of Costello syndrome effectively.

What are the critical complications to monitor?

Proactive care is the cornerstone of managing Costello syndrome. Clinicians must focus on the following high-priority areas to mitigate risks:

• Cardiovascular health: Monitoring for hypertrophic cardiomyopathy and arrhythmias, which occur in a significant percentage of patients.


• Oncological screening: Vigilance for tumors, as individuals with Costello syndrome have an increased predisposition to rhabdomyosarcoma, neuroblastoma, and bladder carcinoma.


• Feeding and growth: Managing severe failure to thrive and gastrointestinal complications often seen in early childhood.


• Developmental support: Addressing global developmental delays and intellectual disability through early intervention services.

How has modern care improved life for those with Costello syndrome?

In past decades, many complications of Costello syndrome were managed only after they became acute. Today, standardized surveillance guidelines—such as those recommended by the NIH—have transformed the management of Costello syndrome. By performing regular echocardiograms, abdominal ultrasounds, and developmental assessments, the medical community can identify issues before they become life-threatening, allowing patients to reach adulthood with a much higher quality of life than previously expected.

Next steps

• Consult with a clinical geneticist to confirm the HRAS mutation and establish a surveillance schedule.


• Connect with the 13 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Reach out to the Costello Syndrome Family Network for specialized resources and support.


• Maintain a comprehensive "medical passport" detailing your child’s specific specialists and screening history.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Costello Syndrome.


• Orphanet: Costello Syndrome (ORPHA:205).


• OMIM (Online Mendelian Inheritance in Man): HRAS-related syndromes.


• Costello Syndrome Family Network: Clinical Guidelines and Resources.